We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+12.45%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$1.3B
AUM Growth
+$126M
Cap. Flow
+$12.8M
Cap. Flow %
0.98%
Top 10 Hldgs %
49.24%
Holding
85
New
28
Increased
16
Reduced
23
Closed
13

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$31.9M
2
DHR icon
Danaher
DHR
+$31.9M
3
HUM icon
Humana
HUM
+$27.8M
4
MOH icon
Molina Healthcare
MOH
+$25.5M
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$23.6M

Sector Composition

Rank Sector Weight
1 Healthcare 87.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DHR icon
76
Danaher
DHR
$141B
-161,413
Closed -$31.9M
ERAS icon
77
Erasca
ERAS
$6.34B
-1,072,224
Closed -$1.36M
HOLX
78
DELISTED
Hologic
HOLX
-211,986
Closed -$13.8M
IOBT
79
DELISTED
IO Biotech
IOBT
-1,972,073
Closed -$2.74M
MASI
80
DELISTED
Masimo
MASI
-94,451
Closed -$15.9M
MOH icon
81
Molina Healthcare
MOH
$10B
-85,739
Closed -$25.5M
SGMT icon
82
Sagimet Biosciences
SGMT
$540M
-90,000
Closed -$686K
UNH icon
83
UnitedHealth
UNH
$367B
-34,623
Closed -$10.8M
UNH icon
84
PUT
UnitedHealth
UNH
$367B
-65,000
Closed -$20.3M

Similar funds

PFM Health Sciences's Q3 2025 Portfolio in Review

As of Q3 2025, PFM Health Sciences held 85 positions worth $1.3B, up 11% from $1.17B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

PFM Health Sciences's Q3 2025 filing shows 28 new, 16 increased, 23 reduced and 13 closed positions. Its largest new stake was Universal Health Services: 116,260 shares worth $23.8M. The largest sale was Eli Lilly, an estimated $31.9M.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets, down from 95% a quarter earlier.

  • PFM Health Sciences's largest Q3 2025 buy was Universal Health Services: 116,260 shares worth $23.8M.
  • PFM Health Sciences added most to United Therapeutics in Q3 2025, an estimated $19.9M increase.
  • PFM Health Sciences's biggest Q3 2025 reduction was Eli Lilly, cutting an estimated $31.9M.
  • PFM Health Sciences fully exited Danaher in Q3 2025, selling an estimated $31.9M.
  • PFM Health Sciences's ten largest holdings make up 49% of its $1.3B portfolio in Q3 2025.
  • PFM Health Sciences opened 28 new positions and closed 13 in Q3 2025.
  • PFM Health Sciences's portfolio value rose 11% quarter-over-quarter to $1.3B.

Based on PFM Health Sciences's 13F filing for Q3 2025, filed 14 Nov 2025.